Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase
about
PEGylation of protein-based MRI contrast agents improves relaxivities and biocompatibilitiesPEGylated Adenoviruses: From Mice to MonkeysAlbumin-based drug delivery: harnessing nature to cure diseaseSite-Specific PEGylation of Therapeutic ProteinsOrganic-inorganic hybrid nanoflowers: types, characteristics, and future prospectsDelivery of drugs bound to erythrocytes: new avenues for an old intravascular carrierAutomated solid-phase peptide synthesis to obtain therapeutic peptidesPolymer-drug conjugates: origins, progress to date and future directionsEnhancing clinical islet transplantation through tissue engineering strategies.Multivalent polymers for drug delivery and imaging: the challenges of conjugationEffect of chemical modification of recombinant human acetylcholinesterase by polyethylene glycol on its circulatory longevityPharmaceutical and toxicological properties of engineered nanomaterials for drug deliveryBrain delivery of proteins via their fatty acid and block copolymer modificationsLipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come.Human complement receptor type 1-directed loading of tissue plasminogen activator on circulating erythrocytes for prophylactic fibrinolysisLoading PEG-catalase into filamentous and spherical polymer nanocarriers.Targeted delivery of therapeutics to endothelium.Evaluating intra-articular drug delivery for the treatment of osteoarthritis in a rat model.MnSOD upregulation induces autophagic programmed cell death in senescent keratinocytes.HPMA copolymers: origins, early developments, present, and future.Nanoparticle Probes for the Detection of Cancer Biomarkers, Cells, and Tissues by FluorescenceSmart pH-sensitive nanoassemblies with cleavable PEGylation for tumor targeted drug delivery.Hydrogen/deuterium exchange mass spectrometry for probing higher order structure of protein therapeutics: methodology and applications.Macromolecular therapeuticsAgile delivery of protein therapeutics to CNSReactive oxygen species regulate osteopontin expression in a murine model of postischemic neovascularization.Heterobivalent ligands target cell-surface receptor combinations in vivo.Chitosan-decorated selenium nanoparticles as protein carriers to improve the in vivo half-life of the peptide therapeutic BAY 55-9837 for type 2 diabetes mellitusAnti-angiogenic effects of a mutant endostatin: a new prospect for treating retinal and choroidal neovascularization.Genetic PEGylationEnhanced brain distribution of modified aspartoacylase.Protein-polymer conjugates: synthetic approaches by controlled radical polymerizations and interesting applications.Polymer-Based TherapeuticsControl of hyperuricemia in subjects with refractory gout, and induction of antibody against poly(ethylene glycol) (PEG), in a phase I trial of subcutaneous PEGylated urate oxidaseSpecies differences in the pharmacology and toxicology of PEGylated helper-dependent adenovirusPrevention of benzyl alcohol-induced aggregation of chymotrypsinogen by PEGylation.Nanoparticle PEGylation for imaging and therapy.IgG antibody response to polyethylene glycol-modified adenosine deaminase in patients with adenosine deaminase deficiency.Noninvasive detection of passively targeted poly(ethylene glycol) nanocarriers in tumors.Phase II pilot study of single-agent etirinotecan pegol (NKTR-102) in bevacizumab-resistant high grade glioma.
P2860
Q24594884-9409DFC8-407D-4F20-A0EC-AD79CE3410B5Q24635276-5FB0B650-4707-41DD-B098-6F8F859D3D40Q26765789-C42277C0-250D-49CC-97F5-7074F3AE1321Q26777819-1801F234-C977-4AE6-ABBA-C619459D6259Q26785759-2B7A68FA-FF8A-43A1-B7C2-80DA8A236F08Q26801300-5080ECA5-DF30-4BE2-858A-7BCEE870F797Q27001623-FCFA4ABE-D38C-46C9-AAFE-498D879E0277Q27002505-95B193AC-A70B-415F-8931-A9B3155FFCD1Q27692123-8D22D493-A205-410D-A63A-A6DC7AD71DF3Q27692689-45D85A4B-4071-465F-B039-4204F1AEC7CFQ28344427-053FFE47-5CBE-41A0-895D-C7F2E42B84B1Q28396383-6C9895B0-9C1E-499F-AB3B-E249F52EF338Q30354932-28104EF7-FE39-464C-8552-49DDD8C839A8Q30366990-02D5DDBB-2A5D-4638-9D28-C97EA20C43F3Q30444430-278635F1-DB2D-4301-89C9-1786C75ABBB9Q30475568-53F8C2E2-16AD-41F6-9A96-CE76EF84675BQ30475849-5D02A973-2ADA-4259-9ABD-42D53A927D5CQ33634515-54ADDDF9-CC26-47DE-A24D-F45EE5CEEB4FQ33697866-9B78034F-A974-4AA8-8DE5-4CBBE9E4F8B8Q33719148-5EA2DB51-573B-446F-AF2F-154970E550C1Q33759991-E4EA041C-D08D-4D32-967A-8DA6040F269BQ33794267-038E77CD-5BF8-4A0E-BC2E-B89F80A950CFQ33844511-59658706-D0EB-401B-8DAE-C2D0E2BE6320Q34079574-C166DD3A-BD35-42D6-8A30-69BA55DD49BBQ34079647-A62A00F1-CF7D-4644-8C9B-6EAC90C7091FQ34227711-D450DCDD-8763-45DF-BD22-E8203A9EEA49Q34317386-03C466D1-D525-4E28-864E-E8DC1811D7D8Q34394374-D668C71F-3BE2-4262-A190-120488390A83Q34473329-64999506-DAFF-479B-B105-516515162A98Q34474297-0FF5D8B0-0376-4B2E-AF0E-381C9A6A2509Q34616189-92A9E970-A03C-4C86-85BC-0D52AAA9FA50Q34716081-4BB3BCEC-CC3C-4761-9CB0-359ADF495275Q34781736-312F1C03-1416-4D7D-A62C-FA6F2AEF4E02Q34896117-2E5D52C2-8A63-41D1-A2DB-3290B3B26EE1Q34975214-5E92165D-BB38-47CE-A305-1BC561843555Q35062556-AF7C6139-66A2-4899-BAA8-810ABD4FACE8Q35553193-76636FB3-5D2A-4207-9346-786BE4D38256Q35602714-32485A4F-E3FC-4022-888E-0006918E1E48Q35671286-DBD22BC0-F711-4625-A0AC-8DE60B297380Q35675340-B3118FFF-83EB-4050-AA2B-2719DDA0BBBC
P2860
Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase
description
1977 nî lūn-bûn
@nan
1977 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1977 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1977年の論文
@ja
1977年論文
@yue
1977年論文
@zh-hant
1977年論文
@zh-hk
1977年論文
@zh-mo
1977年論文
@zh-tw
1977年论文
@wuu
name
Effect of covalent attachment ...... life of bovine liver catalase
@ast
Effect of covalent attachment ...... life of bovine liver catalase
@en
Effect of covalent attachment ...... life of bovine liver catalase
@nl
type
label
Effect of covalent attachment ...... life of bovine liver catalase
@ast
Effect of covalent attachment ...... life of bovine liver catalase
@en
Effect of covalent attachment ...... life of bovine liver catalase
@nl
prefLabel
Effect of covalent attachment ...... life of bovine liver catalase
@ast
Effect of covalent attachment ...... life of bovine liver catalase
@en
Effect of covalent attachment ...... life of bovine liver catalase
@nl
P2093
P3181
P1476
Effect of covalent attachment ...... life of bovine liver catalase
@en
P2093
A Abuchowski
N C Palczuk
P304
P3181
P407
P577
1977-06-10T00:00:00Z